Evaluation N-terminal pro-B-type natriuretic peptide and other biochemical parameters in heart failure with or without chronic kidney disease in Kirkuk city

Backgrounds: Individuals who are diagnosed with chronic kidney disease (CKD) are at a significantly increased risk of developing cardiovascular (CV) disease. Aim of the study: This study evaluated N-terminal pro-B-type natriuretic peptide, urea, creatinin, and albumin in heart failure with or without chronic kidney disease. Materials and methods: The study was done at Amal Dialysis Centre, General Kirkuk Hospital Lab and Azadi Teaching Hospital Lab. The age range of the participants was between 18-68 years old. The study was conducted from January to Augest 2023. The current study examined 90 participants that divided in to four groups as: G1=Kidney failure patients (n:23), G2=Heart failure patients (n:22), G3=Heart and kidney failure (n:23), and G4=apparently healthy normal individuals. Results: This study show highly significant increase NT Pro- BNP in G1, G2 and G3(123.88±22.73, 107.86± 20.15, 134.85± 26.05), as compared with G4 (67.19±18.44) at p-value<0.0008. While highly decrease albumin in G1,G2 and G3(4.318±0.486, 4.028±0.991, 5.500± 0.652), as compared with G4 (7.028± 0.991) at p-value <0.01Conclusion: This study concluded increase in NTpro Pro- BNP, urea and creatinin in all three groups as compared with control group and decrease in albumin level.